Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis

The aim of this 12-month retrospective study was to evaluate differences in the outcomes of denosumab alone or denosumab combined with vitamin D and calcium supplementation in patients having osteoporosis (OP) with rheumatoid arthritis (RA). Patients were divided into the denosumab monotherapy group...

Full description

Bibliographic Details
Main Authors: Yukio Nakamura, Takako Suzuki, Tomohiko Yoshida, Hideshi Yamazaki, Hiroyuki Kato
Format: Article
Language:English
Published: MDPI AG 2017-04-01
Series:Nutrients
Subjects:
Online Access:http://www.mdpi.com/2072-6643/9/5/428